T1 and T2 mapping in myocarditis: seeing beyond the horizon of Lake Louise criteria and histopathology

References

• Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2013 Sep 1;34(33):2636–2648.
   PubMed Web of Science ®Google Scholar
• Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012 Feb;59(9):779–792.
   PubMed Web of Science ®Google Scholar
• Cooper LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. New England J Med. Massachusetts Medical Society; 1997 Jun 26;336(26):1860–1866.
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007 Nov 6;116(19):2216–2233.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Botnar R, Kaski JC, et al. Individualized cardiovascular risk assessment by cardiovascular magnetic resonance [Internet]. Future Cardiol. 2014Mar; 10(2):273–289.
   PubMedGoogle Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009 Apr;53(17):1475–1487.
   PubMed Web of Science ®Google Scholar
• Valbuena-López S, Hinojar R, Puntmann VO. Cardiovascular magnetic resonance in cardiology practice: a concise guide to image acquisition and clinical interpretation. Revista Española de Cardiología (English Edition). 2016 Feb;69(2):202–210.
   PubMed Web of Science ®Google Scholar
• Caforio ALP, Adler Y, Agostini C, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial disease. Eur Heart J. 2017 Sep 14;38(35):2649–2662.
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. 1998 May 12;97(18):1802–1809.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Taylor PC, Barr A, et al. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology. 2010 Feb 11;49(3):528–535.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Bratis C, Kitsiou A, et al. CMR assessment of myocarditis in patients with cardiac symptoms during H1N1 viral infection. JACC Cardiovas Imaging. 2011 Mar;4(3):307–309.
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circulation Cardiovasc Imaging. 2012 Jan 17;5(1):102–110.
   PubMed Web of Science ®Google Scholar
• Baeßler B, Schaarschmidt F, Dick A, et al. Mapping tissue inhomogeneity in acute myocarditis: a novel analytical approach to quantitative myocardial edema imaging by T2-mapping. J Cardiovasc Magn Reson. 2015 Dec 23;17(1):165.
   Google Scholar
• Hinojar R, Foote L, Ucar E, et al. Myocardial T2 mapping for improved detection of inflammatory myocardial involvement in acute and chronic myocarditis. J Cardiovasc Magn Reson. BioMed Central; 2014;16(Suppl 1):O63.
   PubMedGoogle Scholar
• Schumm J, Greulich S, Wagner A, et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis [Internet]. J Cardiovasc Magn Reson. BioMed Central; 2014;16(1):14.
   PubMedGoogle Scholar
• Nadel J, Lancefield T, Voskoboinik A, et al. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death [Internet]. Eur Heart J Cardiovasc Imaging. 2015Jan23. DOI:10.1093/ehjci/jeu294
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Peker E, Chandrashekhar Y, et al. T1 mapping in characterizing myocardial disease. Circ Res. American Heart Association, Inc; 2016 Jul 7;119(2):277–299.
   PubMed Web of Science ®Google Scholar
• Hinojar R, Foote L, Arroyo Ucar E, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37-46.
   Google Scholar
• Lurz JA, Luecke C, Lang D, et al. CMR-derived extracellular volume fraction as a marker for myocardial fibrosis: the importance of coexisting myocardial inflammation. JACC Cardiovas Imaging. 2018;11(1):38-45.
   Web of Science ®Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14(1):42.
   PubMedGoogle Scholar
• Hinojar R, Foote L, Sangle S, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–726.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, D’Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circulation Cardiovasc Imaging. 2013 Mar 19;6(2):295–301.
   PubMed Web of Science ®Google Scholar
• Ntusi NAB, Piechnik SK, Francis JM, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis. JACC Cardiovas Imaging. 2015 May;8(5):526–536.
   PubMed Web of Science ®Google Scholar
• Holloway CJ, Ntusi N, Suttie J, et al. Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation. 2013 Aug 19;128(8):814–822.
   PubMed Web of Science ®Google Scholar
• Barison A, Gargani L, De Marchi D, et al. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015 Jan 12;16(1):74–80.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Isted A, Hinojar R, et al. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63-72.
   Web of Science ®Google Scholar
• Tillin T, Hughes AD, Whincup P, et al. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited). Heart. 2014 May 31;100(Suppl 1):60–67.
   PubMed Web of Science ®Google Scholar
• Lurz P, Luecke C, Eitel I, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis. J Am Coll Cardiol. 2016 Apr;67(15):1800–1811.
   PubMed Web of Science ®Google Scholar
• Gilard M, Eltchaninoff H, Donzeau-Gouge P, et al. Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry. J Am Coll Cardiol. 2016 Oct;68(15):1637–1647.
   Web of Science ®Google Scholar
• Child N, Suna G, Dabir D, et al. Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction. Eur Heart J Cardiovasc Imaging. 2017 Dec 11.
   PubMedGoogle Scholar
• Thomas Aretz H. Myocarditis: the Dallas criteria. Hum Pathol. 1987 Jun;18(6):619–624.
   PubMed Web of Science ®Google Scholar
• Mason JW, O’Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. New England J Med. 1995 Aug 3;333(5):269–275.
   PubMedGoogle Scholar
• Maisch B, Bultmann B, Factor S, et al. World Heart Federation consensus conferences’s definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat. 1999;4:3–4.
   Google Scholar
• Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. American Heart Association, Inc; 2010 Aug 31;122(9):90–99.
   Web of Science ®Google Scholar
• Escher F, Lassner D, Kühl U, et al. Analysis of endomyocardial biopsies in suspected myocarditis–diagnostic value of left versus right ventricular biopsy. Int J Cardiol. 2014 Nov 15;177(1):76–78.
   PubMed Web of Science ®Google Scholar
• Greulich S, Kindermann I, Schumm J, et al. Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy. Clin Res Cardiol. Springer Berlin Heidelberg; 2015 Jul 2;105(1):37–52.
   PubMed Web of Science ®Google Scholar
• Schultheiss H-P, Piper C, Sowade O, et al. Betaferon in chronic viral cardiomyopathy (BICC) trial: effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol. Springer Berlin Heidelberg; 2016 Sep;105(9):763–773.
   PubMed Web of Science ®Google Scholar
• Zawadowski G, Klarich K, Moder K, et al. A contemporary case series of lupus myocarditis. Lupus. 2012 Oct 23;21(13):1378–1384.
   PubMed Web of Science ®Google Scholar
• Isted A, Grigoratos C, Bratis K, et al. Native T1 in deciphering the reversible myocardial inflammation in cardiac sarcoidosis with anti-inflammatory treatment. Int J Cardiol. 2016 Jan;203:459–462.
   PubMed Web of Science ®Google Scholar
• De Lazzari M, Fedrigo M, Migliore F, et al. Nonamyloidotic light chain cardiomyopathy: the arrhythmogenic magnetic resonance pattern. Circulation. American Heart Association, Inc; 2016 Apr 5;133(14):1421–1423.
   PubMed Web of Science ®Google Scholar
• Cooper LT. Myocarditis. N Engl J Med. 2009 Apr 9;360(15):1526–1538.
   PubMed Web of Science ®Google Scholar
• Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovas Imaging. 2012 May 5;5:513–524.
   PubMed Web of Science ®Google Scholar
• Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry–multi national results from 57 centers in 15 countries [Internet]. J Cardiovasc Magn Reson. 2013 Jan 18;15(1):9. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23331632&retmode=ref&cmd=prlinks.
   PubMedGoogle Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovas Imaging. 2013 Apr;6(4):501–511.
   PubMed Web of Science ®Google Scholar
• Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009 Nov 16;120(20):1969–1977.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Puntmann VO, Isted A, et al. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis [Internet]. Radiology. 2017 Apr 27;285(1):162732–162772.
   Web of Science ®Google Scholar
• Radunski UK, Lund GK, Stehning C, et al. CMR in Patients With Severe Myocarditis. JACC Cardiovas Imaging. 2014 7;Jul(7):667–675.
   Google Scholar
• Bohnen S, Radunski UK, Lund GK, et al. Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circulation Cardiovasc Imaging. 2015 May 19;8(6):e003073.
   PubMed Web of Science ®Google Scholar
• Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis. J Am Coll Cardiol. 2005 Jun;45(11):1815–1822.
   PubMed Web of Science ®Google Scholar
• Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008 Feb;246(2):401–409.
   PubMed Web of Science ®Google Scholar
• Francone M, Chimenti C, Galea N, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovas Imaging. 2014 Mar;7(3):254–263.
   PubMed Web of Science ®Google Scholar
• Hunter RJ, McCready J, Diab I, et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart. 2012 May 12;98(1):48–53.
   PubMed Web of Science ®Google Scholar
• Weber KT, Sun Y, Bhattacharya SK, et al. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2012 Dec 4;10(1):15–26.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM. Netting insights into fibrosis. Phimister EG, editor. N Engl J Med. 2017 Apr 13;376(15):1475–1477.
   PubMed Web of Science ®Google Scholar
• Abonnenc M, Nabeebaccus AA, Mayr U, et al. Extracellular matrix secretion by cardiac fibroblasts: role of MicroRNA-29b and MicroRNA-30c. Circ Res. 2013 Oct 24;113(10):1138–1147.
   PubMed Web of Science ®Google Scholar
• Coelho-Filho OR, Mongeon FP, Mitchell R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circulation Cardiovasc Imaging. 2013 Jan 15;6(1):134–141.
   PubMed Web of Science ®Google Scholar
• Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15(1):91.
   PubMedGoogle Scholar
• Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35.
   PubMedGoogle Scholar
• Chu GCW, Flewitt JA, Mikami Y, et al. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging. Springer Netherlands; 2013 Jun;29(5):1077–1083.
   PubMed Web of Science ®Google Scholar
• Hermentin P, Cuesta-Linker T, Weisse J, et al. Comparative analysis of the activity and content of different streptokinase preparations. Eur Heart J. 2005 May 25;26(9):933–940.
   PubMed Web of Science ®Google Scholar
• Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis. J Am Coll Cardiol. 2012 May;59(18):1604–1615.
   PubMed Web of Science ®Google Scholar
• Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013 Mar 6;309(9):896.
   PubMed Web of Science ®Google Scholar
• Knobelsdorff-Brenkenhoff VF, Schüler J, Dogangüzel S, et al. Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance. Circulation Cardiovasc Imaging. American Heart Association, Inc; 2017 Feb;10(2):e005242.
   PubMed Web of Science ®Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. T1 mapping for the diagnosis of acute myocarditis using CMR. JACC Cardiovas Imaging. 2013 Oct;6(10):1048–1058.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovas Imaging. 2013 Apr;6(4):475–484.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Arroyo Ucar E, Hinojar Baydes R, et al. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension. 2014 Sep 10;64(4):762–768.
   PubMed Web of Science ®Google Scholar
• Vo P, Carr-White G, Jabbour A, et al. T1-mapping and outcom in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2016 Jan;9(1):40–50.
   PubMed Web of Science ®Google Scholar
• Rogers T, Dabir D, Mahmoud I, et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study. J Cardiovasc Magn Reson. 2013;15(1):78.
   PubMedGoogle Scholar
• Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol. 2012;24(4):401-407.
   Google Scholar
• Mavrogeni S, Spargias C, Bratis C, et al. Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. Eur J Heart Fail. 2011 Aug;13(8):830–837.
   PubMed Web of Science ®Google Scholar
• Mahrholdt H. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004 Mar 16;109(10):1250–1258.
   PubMed Web of Science ®Google Scholar
• Baldeviano GC, Barin JG, Talor MV, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res. 2010 May 27;106(10):1646–1655.
   PubMed Web of Science ®Google Scholar